Search
Search Constraints
You searched for: Date 2018 Author/Creator Rodrigues, Robim M.Limit your search
- Rodrigues, Robim M. [remove] 4
- 363.179 2
- 615.105 2
- Médicaments -- Recherche -- Périodiques 2
- Pharmacologie -- Périodiques 2
- Pharmacology -- Periodicals 2
- Research -- Periodicals 2
- Toxicology -- Periodicals 2
- ACC1 acetyl-coenzyme A carboxylase 1 -- AdipoR adiponectin receptor -- AOP adverse outcome pathway -- AP-1 activator protein 1 -- APOB apolipoprotein B -- ASC adult stem cells -- α-SMA alpha smooth muscle actin -- CCL C-C chemokine ligand -- CCR C-C chemokine receptor -- CD36 cluster of differentiation 36 -- CHOP CCAAT/enhancer-binding protein homologous protein (CHOP) -- ChREBP carbohydrate-responsive element-binding protein -- CK-18 cytokeratin 18 -- COL collagen type -- CPT-1 carnitine palmitoyltransferase 1 -- CYP cytochrome P450 -- DAMPs danger-associated molecular patterns -- ECM extracellular matrix -- ER endoplasmic reticulum -- ESC embryonic stem cells -- FABP fatty acid-binding protein -- FAE fatty acid elongase -- FAS fatty acid synthase -- FATP-2/5 fatty acid transport protein-2/5 -- FFA free fatty acid -- FXR farnesoid X receptor -- GLP-1 glucagon-like peptide-1 -- HDL high-density lipoprotein -- HMG-CoA 3-hydroxy-3-methyl-glutaryl-coenzyme A -- hSKP-HPC human skin-derived precursors-hepatocyte-like cells -- IL interleukin -- iPSC induced pluripotent stem cells -- LPS lipopolysaccharide -- LXR-α liver X receptor α -- MBOAT7 membrane bound O-acyltransferase domain containing 7 -- MPR misfolded protein response -- NAFLD non-alcholic fatty liver disease -- NASH non-alcoholic steatohepatitis -- NF-κB nuclear factor-kappa B -- NLRP3 nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 3 -- OCA obeticholic acid -- PAMPs pathogen-associated molecular patterns -- PHH primary human hepatocytes -- PNPLA3 patatin-like phospholipase domain-containing protein 3 -- PPAR peroxisome proliferator-activated receptor -- PUFA polyunsaturated fatty acid -- PXR pregnane X receptor -- ROS reactive oxygen species -- SCD1 stearoyl-coenzyme A desaturase 1 -- SREBP-1c sterol regulatory element-binding protein -- TGF-β transforming growth factor-β -- TLR toll-like receptor -- TM6SF2 transmembrane 6 superfamily 2 -- TNF-α tumor necrosis factor-α -- UPR unfolded protein response -- VLDL very low-density lipoprotein 1
- ACN acetonitrile -- ADP adenosyl-diphosphate -- AM/MS accurate mass/mass spectrometry -- ATP adenosyl-triphosphate -- BHT butyl-hydroxytoluene -- CAWG chemical analysis working group (metabolomics society) -- Cer ceramide -- CHCl3 chloroform -- DG diacylglycerol -- DIL concentration 1/10 of IC10 -- DILI drug-induced liver injury -- EDTA ethylenediaminetetra-acetic acid -- FA formic acid -- FDR false discovery rate -- HAc acetic acid -- HILIC hydrophilic interaction liquid chromatography -- HMDB human metabolome database -- IC10 inhibitory concentration 10% -- IPA isopropanol -- LC liquid chromatography -- LPC lysophosphatidylcholine -- LPE lysophosphatidylethanolamine -- MeOH methanol -- MFE molecular feature extractor algorithm -- MFG molecular formula generator algorithm -- mRSD median relative standard deviation -- MS mass spectrometry -- MSI metabolomics standards initiative -- MS/MS tandem mass spectrometry -- MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) tetrazolium -- NAFLD non-alcoholic fatty liver disease -- NASH non-alcoholic steato-hepatitis -- NH4Ac ammonium acetate -- (NH4)2CO3 ammonium carbonate -- NH4F ammonium formate -- NR neutral red -- NRU neutral red uptake -- PBS phosphate buffer saline -- PC phosphatidylcholine -- PCA principal component analysis -- PE phosphatidylethanolamine -- PLS-DA partial least squares discriminant analysis -- QC quality control -- QTOF quadrupole time of flight mass spectrometer -- RP-LC reversed phase liquid chromatography -- RSD relative standard deviation -- SAMe S-adenosylmethionine -- SM sfingomyelin -- TCA tri-carboxylic acid cycle -- TG triglyceride -- VIP variable importance projection -- VLDL very-light density lipoprotein -- NaVPA sodium valproate 1
- CADs cationic amphiphilic drugs -- DIPL drug-induced phospholipidosis -- hSKP human skin-derived precursors -- hSKP-HPC hSKP-derived hepatic progenitor cells -- LBs lamellar bodies -- PL phospholipids -- NL neutral lipids 1